Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Yankees Rumors

Previewing Upcoming Opt-Out Decisions And Player Options

By | at

With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.

Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.

Note: All stats referenced are through play Sunday

Elite Potential Free Agents

  • Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)

Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.

That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).

On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).

  • Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)

Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.

Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).

There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.

Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.

One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.

  • Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)

There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.

deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.

While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.

Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.

Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.

The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.

We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.

Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.

Quality Regulars Likely To Opt Out

Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.

That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.

The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.

Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.

Starting Pitchers With High Buyouts

Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.

Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.

Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.

Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).

Easy Calls To Return

  • Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)

Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.

  • Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)

Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.

  • Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)

Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.

  • AJ Pollock, White Sox LF ($11MM option, $5MM buyout)

The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.

The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.

Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.

Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.

The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.

Relievers

  • Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)

Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.

Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.

Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.

That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.

San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.

Yankees Sign Chi Chi Gonzalez, Jacob Barnes To Minor League Deals

By | at

The Yankees have signed a trio of pitchers — Chi Chi González, Jacob Barnes and Wilking Rodríguez — to minor league contracts, tweets Conor Foley of the Scranton Times-Tribune. All three have been assigned to Triple-A Scranton/Wilkes-Barre.

González and Barnes were recently together in the Tigers system, but both were each granted their release from non-roster pacts with Detroit. González has now joined four organizations this year. He began the season with the Twins, bouncing on and off the major league roster twice. Claimed off waivers by the Brewers, he combined to work 18 1/3 innings over six appearances (four starts). González posted a 6.87 ERA — his third consecutive season with an ERA north of 6.00 — between the two clubs, and he was eventually outrighted off Milwaukee’s roster.

The 30-year-old righty signed a minor league deal with Detroit in late July. He spent a month in the system but didn’t get a big league call, and he triggered an opt-out clause last week. Between the Twins and Tigers top minor league affiliates, González has worked to a 4.19 ERA through 58 Triple-A innings this season. He has plenty of starting experience in both the majors and upper minors, giving the Yankees a multi-inning depth arm.

Barnes is on his third organization of the season. The right-hander broke camp with Detroit after signing an offseason minor league deal. He appeared in 22 games but was tagged for a 6.10 ERA over 20 2/3 innings. He racked up grounders on over half the batted balls against him, but he only struck out 11.2% of batters faced. The lack of swing-and-miss was bizarre, as Barnes posted above-average strikeout rates in 2020 and ’21 and was still averaging a robust 95.5 MPH on his fastball.

Detroit took Barnes off their big league roster in mid-June. The 32-year-old signed a minor league deal with the Mariners and was briefly called up, but he didn’t appear in an MLB game with Seattle before being designated for assignment. Barnes again cleared waivers, elected free agency, and returned to Detroit on a minor league deal in late July. He spent a month in Triple-A before being granted his release. While his MLB production this year has been lackluster, Barnes has an excellent 17:3 strikeout-to-walk ratio while allowing just two runs in ten Triple-A innings.

Rodríguez, 32, makes a long-awaited return to the affiliated ranks. The right-hander has the briefest of major league experience, having come out of the bullpen twice for the 2014 Royals. He hasn’t played for an MLB organization since a seven-game Triple-A stint with the Yankees in 2015, as he’d primarily played winter ball over the past six years. Rodríguez has spent 2022 in the Mexican League, posting a 2.01 ERA over 44 2/3 innings and apparently impressing Yankees evaluators with his arsenal.

All three pitchers would be eligible for New York’s postseason roster if they impress enough to warrant a spot in October. Players need to be within an organization by September 1 to suit up for that club in the playoffs. Any player on a 40-man roster or MLB injured list by the end of August is automatically postseason-eligible (unless they’d been suspended for a performance-enchancing drug violation that season). Those within the organization but not on the 40-man at the start of September can still be added to the postseason roster to replace a player on the injured list via petition to the commissioner’s office.

Jon Heyman of the New York Post first reported González was signing with the Yankees.

Yankees Sign Chasen Shreve To Minors Contract

By | at

The Yankees have signed Chasen Shreve to a minor league contract, according to the club’s official MLB.com transactions page.  Shreve hinted on his Instagram page Friday (hat tip to Conor Foley of the Scranton Times-Tribune) that he was headed for a return stint with the Yankees organization.

The left-hander previously pitched for the Yankees from 2015-18, until he and Giovanny Gallegos were dealt to the Cardinals for Luke Voit and $1MM in international bonus pool money in July 2018.  Shreve also returned to New York in two separate stints with the Mets, both in 2020 and earlier this season.

The Mets released Shreve in July, after the lefty posted a 6.49 ERA over 26 1/3 innings.  This tenure ended in particularly disastrous fashion, as Shreve was crushed for 10 runs over the last 5 1/3 of those frames.  Opposing batters have hit six home runs off Shreve in those 26 1/3 innings, a resurgence of the homer problem that has periodically hampered him during his nine years in the majors.

Between the homers and some command issues, consistency has often hard to come by for Shreve, but he has been quite effective when at his best.  It was just last season that Shreve had a 3.20 ERA over 56 1/3 innings with the Pirates, as despite mediocre strikeout and walk rates, Shreve was one of the league’s best at limiting hard contact.

Shreve had a 3.92 ERA over his 174 2/3 previous innings with the Yankees, exhibiting some of those same ups and downs that have defined his career.  He is the second experienced left-hander added by the Bronx Bombers in two days, with Anthony Banda signed to a Major League deal today.  The Yankees look to be adding southpaw depth in advance of the postseason, and in the wake of Aroldis Chapman’s placement on the 15-day injured list yesterday.

Yankees Sign Anthony Banda

By | at

1:23PM: The Yankees officially announced that Banda was signed to a Major League contract.  To create roster space, right-hander Luis Gil (who underwent Tommy John surgery in May) was recalled from the minors and moved to the 60-day injured list.

1:01PM: The Yankees have agreed to a deal with left-hander Anthony Banda.  ESPN’s Marly Rivera was among the reporters to note earlier today that Banda was present in the Yankees’ clubhouse.

With Aroldis Chapman going on the 15-day injured list yesterday, New York quickly filled that void with another left-handed reliever.  Banda joins Wandy Peralta and Lucas Luetge as the southpaw options in an injury-plagued bullpen, though Chapman and Zack Britton are expected to be back at some point in September.

The Yankees will be the ninth different organization of Banda’s career, and he has been action at the MLB level with five of those teams.  That includes a combined 26 innings with the Pirates and Blue Jays this season, with a 5.88 ERA to show for Banda’s 2022 resume.  Advanced metrics paint a much more favorable picture of Banda’s performance than his ERA, as a gigantic .446 BABIP might be to blame for many of Banda’s struggles.

Banda was a notable prospect early in his career before he was waylaid by injuries, and the second act of his career has seen the left-hander now convert to full-time relief pitching.  He has a 4.98 ERA over 59 2/3 innings since the start of the 2021 season, though a 3.90 SIERA in that same span is perhaps a better reflection, given Banda’s lack of batted-ball luck.

Toronto acquired Banda from Pittsburgh in early July, and Banda than chose free agency rather than accept an outright assignment to Triple-A in early August.  That led to a new minors deal with the Mariners, but he made only four appearances with Seattle’s Triple-A affiliate before enacting an opt-out clause earlier this week.

Yankees Place Aroldis Chapman On 15-Day Injured List

By | at

7:06PM: The Yankees officially placed Chapman on the 15-day IL, retroactive to August 24.

6:14PM: The Yankees will place left-hander Aroldis Chapman on the 15-day injured list due to a leg infection, manager Aaron Boone told the YES Network’s Jack Curry (Twitter links) and other reporters.

Chapman last pitched on August 19, and Boone said part of that layoff has been due to the reliever’s battle with an infection that developed after Chapman got a leg tattoo.  Boone stated that he believes Chapman will pitch again this season, but the lefty will now be out until at least the second week in September, even accounting for a few days of backdating on his IL placement.

The unusual injury adds to what has been a tough season for Chapman, who already missed over five weeks due to left Achilles tendinitis.  By the time Chapman returned to the active roster, Clay Holmes had taken over as New York’s closer, leaving Chapman relegated to lower-leverage roles rather than even a solid set-up job.  Since beginning his season with 10 1/3 scoreless innings, Chapman has struggled to a 7.08 ERA over his last 20 1/3 innings of work.

Even with Chapman far less than his usual effective self, his IL placement is another hit to a bullpen that has suddenly been crushed by injuries over the last couple of months.  Holmes may be back from his own IL stint within a few days’ time, but Holmes and Chapman are joined by Scott Effross, Miguel Castro, Zack Britton, and Albert Abreu on the injured list, while Michael King and Chad Green have already been ruled out for the rest of the season.  Wandy Peralta and Lucas Luetge are the only remaining left-handers in New York’s relief corps now that Chapman is out.

The Yankees entered Saturday’s action with a comfortable 8.5-game lead in the AL East, as an ongoing five-game winning streak has eased some concerns after a mediocre stretch of play since the All-Star break.  Getting some of those injured relievers back before the playoffs will further bolster New York’s chances in October, but in Chapman’s case, the question must be asked whether the Yankees could conceivably leave him off a playoff roster altogether.

While Chapman is a seasoned playoff performer with a 2016 World Series ring to show from his time with the Cubs, he’ll need to return in good health and then deliver some consistent outings in September to clinch his spot for the postseason.  This is also the last season of Chapman’s three-year, $48MM contract, so a platform for free agency is also undoubtedly on Chapman’s mind.

Yankees Select Greg Weissert

By | at

5:56pm: New York officially announced Wiessert’s selection, as well as the previously-reported placement of Nestor Cortes on the 15-day IL and the reinstatement of Giancarlo Stanton. In order to create a spot on the 40-man roster, New York transferred center fielder Harrison Bader from the 10-day to the 60-day IL. Bader has already been on the IL since June 27, so the move is procedural and doesn’t affect his return window. Bader, who’s dealing with plantar fasciitis in his right foot, hasn’t yet begun a minor league rehab assignment.

11:57am: The Yankees will select the contract of right-hander Greg Weissert prior to tomorrow’s game with the Athletics, according to Eric Hubbs of Barstool Sports (Twitter link).  A corresponding move will need to be made to officially add Weissert to the 40-man roster, and the New York Post’s Joel Sherman reports that the Yankees will be placing another pitcher on the injured list.

Weissert’s first MLB appearance will be his debut in the Show.  An 18th-round pick out of Fordham in the 2016 draft, Weissert posted solid but unspectacular numbers in his first pro seasons before returning with a flourish after the canceled 2020 minor league season.  The right-hander has been getting better as he has gotten closer to the majors, with a 1.47 ERA over 36 2/3 innings of Double-A ball and a 1.85 ERA in 82 2/3 Triple-A frames.

This season has seen Weissert deliver a 36.8% strikeout rate in 46 innings of Triple-A ball, which is more than enough to counter a more average 10.4% walk rate.  Batters have simply not been able to do much against Weissert this year, with only 22 total hits.  Over his last 23 games and 23 1/3 innings, Weissert also hasn’t allowed a single run, either earned or unearned.

The bullpen went from being a major strength to more of a question mark for the Yankees in recent weeks, as Chad Green and Michael King were both lost to season-ending injuries and the likes of Clay Holmes, Miguel Castro, Albert Abreu, and — just yesterday — trade deadline acquisition Scott Effross were also lost to the injured list.  Weissert will provide some reinforcement, while Holmes, Castro, and Zach Britton are all on the way back, though it remains to be seen which new pitcher (as per Sherman’s report) has now also been sidelined.

Florida Notes: Marlins, Rays, Lopez, Rojas, Yankees, Franco, Baz, Cooper

By | at

The Yankees were known to be targeting Pablo Lopez prior to the trade deadline, and reports suggested that Gleyber Torres was involved in the talks between New York and Miami.  One trade proposed by the Marlins would’ve seen Lopez and Miguel Rojas head to the Bronx in exchange for Torres and infield prospect Oswald Peraza, The Athletic’s Ken Rosenthal reports, but the Yankees rejected the offer.

Anthony Volpe is considered one of the top prospects in all of baseball, so while Peraza is a top-100 staple in his own right, he could’ve been more of an expendable piece in trade talks.  New York was still resistant to moving Peraza, and while the club was reportedly open to moving him in a possible Frankie Montas trade, the Yankees ended up landing Montas from the Athletics for another trade package that didn’t involve Peraza.  The inclusion of longtime Miami staple Rojas is an interesting wrinkle, as presumably the Marlins offered Rojas as a replacement for Torres in the Yankees’ infield mix, and perhaps sought to give the veteran a chance at winning a ring with a contender.  It makes for an interesting deadline what-if, and any of these players could potentially be part of different trade talks should the two teams rekindle negotiations this winter.

Some rumblings from the Marlins and Rays, as we check in on both Sunshine State teams…

  • After some fielding drills and batting practice on Wednesday, Wander Franco told reporters (including Marc Topkin of the Tampa Bay Times) that “I feel super good right now and [am] getting better,” in regards to his injured right hand.  Soreness in that hand led Franco to be taken off his rehab assignment earlier this week, and the Rays will continue to monitor Franco’s injury before deciding when to restart his minor league work.  Speaking with Topkin and company today, Rays manager Kevin Cash said Saturday would be the earliest date for Franco to resume his rehab assignment.  Franco has played in only 58 games this season due to a quad strain and then hamate-bone surgery, and his return would be a big boost to a Rays club that is trying to secure a wild card berth.
  • In other Rays injury updates from Topkin, Josh Fleming and Matt Wisler each started minor league rehab assignments within the last two days, while J.P. Feyereisen will throw a live batting practice session before the team decides on his rehab assignment.  This is a good development for Feyereisen, who had a brief setback due to shoulder soreness earlier this month.  Shane Baz also told Topkin and other reporters that he’ll start a throwing program on Monday, but it remains to be seen if Baz can get fully ramped up in time to return to big league game action before the season is over.  An elbow sprain sent Baz to the 15-day IL and then the 60-day IL retroactive to July 14, so it will still be a few weeks before he is even eligible to be activated.
  • Garrett Cooper is two games into a minor league rehab assignment and could be back on the Marlins’ active roster as soon as Friday.  Manager Don Mattingly told reporters that Cooper was slated to play three games as part of his recovery from a stint on the seven-day concussion IL, and Cooper is no longer experiencing any symptoms.  Cooper’s IL placement was retroactive to August 17, and it doesn’t look like he’ll miss much more time beyond the seven-day minimum.

Yankees To Place Nestor Cortes On 15-Day Injured List

By | at

The Yankees will place left-hander Nestor Cortes on the 15-day injured list prior to tomorrow’s game, according to The Athletic’s Lindsey Adler.  Cortes is suffering from a groin injury.  As reported earlier today, New York was preparing to place a then-unknown pitcher on the IL to make room for the promotion of minor league right-hander Greg Weissert.

While any pitching injury would’ve been a setback, losing Cortes for any amount of time is a tough blow to the Bronx Bombers.  “Nasty Nestor” has been arguably the Yankees’ best starter this season, and one of the better pitchers in all of baseball.  After surprisingly emerging as a rotation stalwart in 2021, Cortes has kept on rolling, posting a 2.68 ERA and above-average strikeout (25.9%) and walk (5.8%) rates over 131 innings of work.  Despite a low-velocity four-seamer, Cortes’ fastball has been extremely effective, and his cutter isn’t far behind in terms of sheer effectiveness.

Though Cortes’ 131 innings is a new career high for the 27-year old over any pro season, there hasn’t been much sign that Cortes is slowing down, and he was expected to be a big weapon for the Yankees in October.  This 15-day IL stint could perhaps serve as a bit of break in terms of keeping Cortes’ arm fresh, though naturally his groin issue is now a new concern.  The severity of the injury or a possible timeline for Cortes’ return isn’t yet known.

New York enjoyed a great run of pitching health over the first half of the season, but several injuries have cropped up in recent weeks.  The bullpen has taken the brunt of the injury woes, but the rotation hasn’t been immune, with Luis Severino out until mid-September due to a lat strain and now Cortes’ injury.  The Yankees acquired Frankie Montas from the A’s at the deadline but also moved Jordan Montgomery to the Cardinals in another trade, plus Domingo German has been a little inconsistent (if generally solid) since making his season debut in July, after shoulder problems kept him on the sidelines.

Clarke Schmidt was recently called back up to the active roster, and the former first-rounder seems like the probable candidate to step into Cortes’ rotation spot.  Over 22 games and 45 2/3 career innings at the MLB level in 2020-22, Schmidt has only made three starts, but the Yankees have mostly been using him in long relief this season and were stretching him out at Triple-A.

Yankees Notes: Stanton, Florial, Britton

By | at

The Yankees are expected to reinstate Giancarlo Stanton, who has been on the shelf since late July due to tendinitis in his left Achilles, prior to tomorrow’s series opener in Oakland. Stanton was on the field going through a full pre-game routine yesterday, per ESPN’s Marly Rivera (Twitter link with video). The Yankees already announced following last night’s game that outfielder Estevan Florial has been optioned to Triple-A Scranton/Wilkes-Barre, which seems to further set the stage for Stanton’s return.

Stanton, 32, has had a productive season at the plate in terms of power output and run production, belting 24 homers and plating 61 runs through just 324 trips to the plate. After an excellent first two months at the plate — Stanton hit .285/.339/.523 through the end of May — he’s been more of a pure “three true outcomes” slugger in the summer months of the season.

Since the calendar flipped to June, a whopping 56% of Stanton’s hits have been home runs (13 of 23). He’s batting just .167 in 40 games since June 1, but he’s still walking at a strong 13.1% clip and obviously flexing his power. Exactly half of his plate appearances have ended in a strikeout, walk or home run in that time. Stanton’s .167/.277/.471 slash dating back to June has dropped his season-long line to .228/.309/.498. That’s still 28% better than league average, per both wRC+ and OPS+, but the Yankees and Stanton alike will surely be hoping for a more balanced set of results when he returns.

Stanton will return to the lineup at a time when the Yankees’ offense has been stumbling through one of its driest spells of the year. The Yanks are just 7-14 this month and have plated only 70 runs in those 21 contests — an average of 3.33 runs per game (all while allowing 89 runs in August). They’ve been held to four or fewer runs in 13 of their past 15 contests.

Florial’s return to the big leagues will prove quite brief. There was optimism among Yankee fans when he was promoted on the heels of a .286/.368/.490 showing in Scranton, but he wound up starting just three games, going 1-for-9 with four strikeouts in that tiny sample. The former top prospect, like many Yankee farmhands in recent years, has yet to receive an earnest audition at the MLB level, receiving just 50 plate appearances over the past three seasons (and hitting just .186/.302/.300 in those sparse opportunities).

Stanton isn’t the only veteran reinforcement on the horizon for the Yanks, it should be noted. Lefty Zack Britton, who has yet to pitch in 2022 while rehabbing from last year’s Tommy John surgery, is set to embark on a minor league rehab assignment today, tweets Meredith Marakovits of the YES Network.

The 34-year-old lefty has been a vital part of the Yankees’ late-inning relief corps when healthy, logging 123 2/3 innings of 2.69 ERA ball while brandishing one of the game’s most notoriously devastating sinkers. It’ll take a bit of time for Britton to build up to readiness for a big league return, of course, but the commencement of a rehab assignment means that both he and injured closer Clay Holmes could return to the bullpen in the near future. If Holmes is back to form after a brief trip to the injured list, the Yankees can deploy two of the game’s premier sinker/grounder specialists to help lock things down late in games.

Yankees Place Scott Effross On IL With Shoulder Strain

By | at

Yankees right-hander Scott Effross is going on the 15-day injured list with a shoulder strain, according to manager Aaron Boone, courtesy Lindsey Adler of The Athletic. Boone characterizes the strain as minor but says that Effross will be shut down from throwing for 7-10 days, per Chris Kirschner of The Athletic. Fellow righty Clarke Schmidt will take his place on the active roster.

It’s yet another blow to a Yankee relief corps that has seen its fair share of them this year. Earlier in the campaign, they lost Chad Green to Tommy John surgery. In July, Michael King suffered a season-ending elbow fracture. That month also saw Miguel Castro land on the shelf due to a shoulder strain. Here in August, the club has seen Clay Holmes and Albert Abreu go on the IL due to back spasms and elbow inflammation, respectively.

Effross, 28, was acquired from the Cubs prior to the trade deadline and immediately jumped into the mix for high leverage work in the Bronx. He recorded a hold in his second appearance with the club, later tallying a save as well. Unfortunately, the club will now have to get by without him as an option, at least for a few weeks. He’s thrown 52 1/3 innings this year between Chicago and New York, registering a 2.75 ERA with a 27.5% strikeout rate, 6.2% walk rate and 43.1% ground ball rate.

While the loss of Effross is certainly bad news, the Yankees got good news about their bullpen elsewhere. Holmes has started throwing bullpens without physical issues, per Meredith Marakovits of the YES Network, meaning he’s on track to return soon. Miguel Castro has started throwing as well, per Marly Rivera of ESPN, and could progress to throwing a bullpen by Friday. And in non-bullpen news, Boone tells Rivera that the plan for slugger Giancarlo Stanton is to be activated from his rehab assignment on Thursday.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top